Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
  • General Material Designation
    See More
  • Location
  • Language
Found 2 from your keywords: author=Budi Setiawan
cover
The Expression of HIF-1α in Diffuse Large B-cell Lymphoma (DLBCL) Patients: …
Comment Share
Eko Adhi Pangarsa, MDDaniel Rizky, MDKevin Tandarto, MDRidho M. Naibaho, MDSigit P. Kurniawan, MDHermawan Istiadi, MDDik Puspasari, MDAntonius Gunawan Santoso, MD, PhDBudi Setiawan, MD, PhDDamai Santosa, MD, PhDSofia Mubarika Haryana, MD, PhDCatharina Suharti, MD, PhD

Introduction: Hypoxia fuels cancer growth by supporting blood vessel formation, suppressing immune response, and helping cancer cells adapt to harsh surroundings. This happens when cancer cells react to low oxygen levels by activating hypoxia inducible factor-1 alpha (HIF-1α). High levels of HIF-1α can indicate an aggressive form of cancer and resistance to treatment in diffuse large B-cel…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
616.99483 Eko t
cover
The Efectiveness of Atorvastatin for The Prevention of Deep Vein Thrombos…
Comment Share
Budi SetiawanWidi BudiantoTri Wahyu SukarnowatiDaniel RizkyEko Adhi PangarsaDamai SantosaAru Wisaksono SudoyoTri Indah WinarniIgnatius RiwantoRahajuningsih Dharma SetiabudyCatharina Suharti

Background Deep vein thrombosis (DVT) is a common complication in cancer. Although thromboprophylaxis in cancer patients is recommended by the guidelines, clinicians’ use of thromboprophylaxis remains limited due to cost, bleeding complications, and reluctance to give injectable anticoagulants. Infammation plays essential roles in the pathogenesis of cancer-associated thrombosis. Owing to …

Edition
-
ISBN/ISSN
1477-9560
Collation
-
Series Title
-
Call Number
616.15 Bud t